Detalhe da pesquisa
1.
ASPiRATION: Australian observational cohort study of comprehensive genomic profiling in metastatic lung cancer tissue.
Future Oncol
; 20(7): 361-371, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37767626
2.
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trial.
Transl Oncol
; 43: 101914, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38417292
3.
Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma-a phase 3 randomised trial.
BMJ Open
; 12(1): e057663, 2022 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078853
4.
Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.
BMJ
; 379: e072175, 2022 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384746
5.
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA).
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612250
6.
Use of adenoviruses to study isoform specificity of G-protein-receptor-coupled Ca2+ signaling in intact epithelial cells.
Cell Biochem Biophys
; 36(2-3): 221-33, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-12139408
7.
Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.
J Clin Oncol
; 29(19): 2675-82, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21646616
8.
Negative regulation of Ca(2+) influx during P2Y(2) purinergic receptor activation is mediated by Gbetagamma-subunits.
Cell Calcium
; 47(1): 55-64, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20056275
9.
Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
J Clin Oncol
; 28(19): 3191-8, 2010 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20516443